Source comparison
TB-500 Help Achilles Tendonitis: Equipment and Monitoring Comparison
Baseline Imaging Diagnostic ultrasound or MRI to establish tendon thickness, tear presence, neovascularity. Allows pre/post comparison Same diagnostic standard applies No additional risk. Imaging is standard of care Injection Frequency Twice weekly subcutaneou
This comparison does not assign a generated winner or score.
- Baseline Imaging
- Diagnostic ultrasound or MRI to establish tendon thickness, tear presence, neovascularity. Allows pre/post comparison
- Same diagnostic standard applies
- No additional risk. Imaging is standard of care
- Injection Frequency
- Twice weekly subcutaneous or intramuscular for 4–8 weeks (research-based protocols)
- No injections required for conservative care
- Local site reactions (bruising, infection risk <1%) are primary concerns with repeated injections
- Concurrent Physical Therapy
- Eccentric loading (Alfredson protocol) remains mandatory. TB-500 does not replace mechanical stimulus
- Eccentric loading is first-line treatment; 60–70% success rate at 12 weeks
- TB-500 may theoretically enhance collagen remodeling response to loading, but no human trials confirm additive effect
- Timeline to Measurable Improvement
- Hypothetically 8–10 weeks if animal data translates (versus 12–14 weeks standard)
- 12–14 weeks for VISA-A score improvement ≥20 points in most clinical trials
- Premature return to loading before adequate collagen maturation increases reinjury risk regardless of peptide use
- Cost
- Research-grade TB-500: approximately $180–$300 for 4-week supply (varies by supplier and purity verification)
- Physical therapy co-pays: $30–$75 per session × 8–12 sessions = $240–$900 total
- Adding TB-500 increases total treatment cost by $360–$600 for 8-week protocol without guaranteed incremental benefit
- Professional Assessment
- Requires coordination with prescribing physician for off-label peptide use and storage/administration education
- Physical therapy alone requires MD referral but no peptide oversight
- Self-administration without medical guidance increases protocol error risk (dosage, sterile technique, reconstitution)